207940.KS · 삼성바이오로직스
South Korea · RS rating 14 · As of 2026-10-14
| Price | 1,179,000.00 KRW |
|---|---|
| 1-day change | -2.1% |
| RS rating (overall / 1M / 3M / 12M) | 14 / 8 / 19 / 41 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 24 / 16 / 25 |
| Industry group (rank) | Biotechnology (–) |
| EPS growth Q/Q | -8.2% |
| Sales growth Q/Q | +5.1% |
| Distance from 52-week high | +39.5% |
| Market cap (USD) | $42.3B |